首页 › 基金 › Spruce Street Capital LP › LBRX
Spruce Street Capital LP 对 LBRX 的持仓历史
LB PHARMACEUTICALS INC · 医疗保健
Spruce Street Capital LP 在 Q3 2026 的 13F 申报中披露持有 LBRX(LB PHARMACEUTICALS INC)1,404,779 股,市值约 US$53.9M,约占其申报组合的 8.56%,在其申报持仓中市值排名第 2 位。 Spruce Street Capital LP 最近 4 个申报季度中有 4 个季度披露了 LBRX 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Spruce Street Capital LP 对 LBRX 的持仓演变
Spruce Street Capital LP 于 Q4 2025 首次披露 LBRX 持仓:1,005,593 股(约 US$22.4M)。 该持仓在 Q3 2026 达到峰值 1,404,779 股,市值约 US$53.9M。 在 4 次申报中,Spruce Street Capital LP 2 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 1,404,779 股、市值约 US$53.9M,环比增持 28,620 股。。 持仓曾出现大幅变动:Q1 2026 增持约 37% (随后一个季度股价上涨 32%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 1.01M | $22.38M | 新进 |
| Q1 2026 | 1.38M | $33.64M | 增持 |
| Q2 2026 | 1.38M | $44.66M | 持有 |
| Q3 2026 | 1.40M | $53.86M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LBRX 与 13F 数据
LBRX(LB PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 106 只申报持有 LBRX,申报仓位最大的包括:Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LBRX 的基金
- Deep Track Capital, LP 3.35M 股 · $108.82M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.21M 股 · $71.68M · Q2 2026
- Trails Edge Capital Partners, LP 1.52M 股 · $49.43M · Q2 2026
- Commodore Capital LP 1.50M 股 · $48.68M · Q2 2026
- TCG Crossover Management, LLC 1.45M 股 · $46.97M · Q2 2026
- Caligan Partners LP 1.44M 股 · $46.67M · Q2 2026
- Nantahala Capital Management, LLC 1.07M 股 · $41.23M · Q3 2026
- Vivo Capital, LLC 800.00K 股 · $30.70M · Q3 2026
- Nan Fung Group Holdings Ltd 630.66K 股 · $24.20M · Q3 2026
- Logos Global Management LP 585.00K 股 · $18.99M · Q2 2026
- GREAT POINT PARTNERS LLC 317.22K 股 · $10.30M · Q2 2026
- HighVista Strategies LLC 173.80K 股 · $6.67M · Q3 2026
更多关于 Spruce Street Capital LP
常见问题
How long has Spruce Street Capital LP held LBRX?
Spruce Street Capital LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Spruce Street Capital LP's current position in LBRX?
As of Q3 2026, Spruce Street Capital LP holds 1.40M shares of LBRX (LB PHARMACEUTICALS INC), valued at $53.86M, representing 8.56% of its reported portfolio and ranking #2.
Has Spruce Street Capital LP been buying or selling LBRX?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP increased its position in LBRX. The position peaked in Q3 2026 at 1.40M shares.
Which other funds hold LBRX?
Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, among 106 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.